Targeting Notch3 in Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Perspectives

被引：32
|
作者：
Giovannini, Catia [1 ,2 ]
Bolondi, Luigi [1 ,2 ]
Gramantieri, Laura [1 ]
机构：
[1] S Orsola Malpighi Univ Hosp, Ctr Appl Biomed Res CRBA, I-40138 Bologna, Italy
[2] Univ Bologna, Dept Med & Surg Sci, I-40138 Bologna, Italy
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2017年 / 18卷 / 01期
关键词：
Notch; p53; hepatocellular carcinoma (HCC); GAMMA-SECRETASE INHIBITOR; ACUTE LYMPHOBLASTIC-LEUKEMIA; TUMOR-SUPPRESSOR FUNCTION; PANCREATIC-CANCER CELLS; HUMAN BREAST-CANCER; DOWN-REGULATION; SIGNALING PATHWAY; STEM-CELLS; RECEPTOR EXPRESSION; LATERAL INHIBITION;
D O I：
10.3390/ijms18010056
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The Notch signaling pathway is a very conserved system that controls embryonic cell fate decisions and the maintenance of adult stem cells through cell to cell communication. Accumulating evidence support the relevance of Notch signaling in different human diseases and it is one of the most commonly activated signaling pathways in cancer. This review focuses mainly on the role of Notch3 signaling in hepatocellular carcinoma and its potential therapeutic applications against this malignancy. In this regard, the crosstalk between Notch and p53 may play an important role.
引用
收藏
页数：13
相关论文
共 50 条
  • [11] Investigating Notch3 expression in hepatocellular carcinoma and its interplay with KDM2A
    De Giorgi, I.
    Caruso, T.
    Scavuzzo, M. C.
    Piaggi, S.
    Scolari, F.
    Faviana, P.
    Pillozzi, S.
    Del Frate, R.
    Montagner, G. Paties
    Bartoli, F.
    Corti, A.
    Cavallini, G.
    Carloni, V.
    Gragnani, L.
    DIGESTIVE AND LIVER DISEASE, 2025, 57 : S18 - S18
  • [12] Neuroinflammation Targeting Pyroptosis: Molecular Mechanisms and Therapeutic Perspectives in Stroke
    Yuan, Xiwen
    Xia, Yiwen
    Jiang, Pei
    Chen, Jing
    Wang, Chunmei
    MOLECULAR NEUROBIOLOGY, 2024, 61 (10) : 7448 - 7465
  • [13] Molecular Mechanisms of the Therapeutic Effect of Selenium Nanoparticles in Hepatocellular Carcinoma
    Varlamova, Elena G.
    CELLS, 2024, 13 (13)
  • [14] Mitochondrial Signaling and Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Implications
    Facciorusso, Antonio
    Villani, Rosanna
    Bellanti, Francesco
    Mitarotonda, Domenica
    Vendemiale, Gianluigi
    Serviddio, Gaetano
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (18) : 2689 - 2696
  • [15] Improved sorafenib activity on hepatocellular carcinoma in Notch3 silenced in vivo and in vitro models.
    Baglioni, Michele
    Giovannini, Catia
    Gramantieri, Laura
    Toaldo, Marco Baron
    Ventrucci, Cristiano
    D'Adamo, Stefania
    Cipone, Mario
    Chieco, Pasquale
    Bolondi, Luigi
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [16] MiRNA signatures in nasopharyngeal carcinoma: molecular mechanisms and therapeutic perspectives
    Chen, Yan
    Lin, Ting
    Tang, Le
    He, Lan
    He, Yingchun
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (12): : 5805 - 5824
  • [17] Therapeutic Potential of Targeting Glypican-3 in Hepatocellular Carcinoma
    Allegretta, Mark
    Filmus, Jorge
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2011, 11 (06) : 543 - 548
  • [18] The association of PNPLA3, EGF and Notch3 gene polymorphisms with alcoholic liver disease and hepatocellular carcinoma
    Sisl, Dino
    Bainrauch, Ana
    Markotic, Antonio
    Ostojic, Ana
    Lang, Valerija Bralic
    Bekan, Ivan Budimir
    Opara, Andela Krstulovic
    Kelava, Tomislav
    Mrzljak, Anna
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 306 - 306
  • [19] Hepatocellular carcinoma. Therapeutic perspectives
    Mohr, L.
    GASTROENTEROLOGE, 2007, 2 (01): : 34 - 39
  • [20] P53 IS REGULATED BY NOTCH3 SIGNALLING VIA MDM2 IN HEPATOCELLULAR CARCINOMA
    Minguzzi, M.
    Giovannini, C.
    Gramantieri, L.
    Chieco, P.
    Marcu, K. B.
    Mastroleo, C.
    Piscaglia, F.
    Bolondi, L.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 : S24 - S25
12345